BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22127645)

  • 1. Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II.
    Ballot C; Jendoubi M; Kluza J; Jonneaux A; Laine W; Formstecher P; Bailly C; Marchetti P
    Apoptosis; 2012 Apr; 17(4):364-76. PubMed ID: 22127645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.
    Brel V; Annereau JP; Vispé S; Kruczynski A; Bailly C; Guilbaud N
    Biochem Pharmacol; 2011 Dec; 82(12):1843-52. PubMed ID: 21924246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II.
    Chelouah S; Monod-Wissler C; Bailly C; Barret JM; Guilbaud N; Vispé S; Käs E
    PLoS One; 2011; 6(8):e23597. PubMed ID: 21853156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS
    Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.
    Chen MC; Pan SL; Shi Q; Xiao Z; Lee KH; Li TK; Teng CM
    Cancer Sci; 2012 Jan; 103(1):80-7. PubMed ID: 21920000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
    Mouawad F; Gros A; Rysman B; Bal-Mahieu C; Bertheau C; Horn S; Sarrazin T; Lartigau E; Chevalier D; Bailly C; Lansiaux A; Meignan S
    Oral Oncol; 2014 Feb; 50(2):113-9. PubMed ID: 24290982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage.
    Gentry AC; Pitts SL; Jablonsky MJ; Bailly C; Graves DE; Osheroff N
    Biochemistry; 2011 Apr; 50(15):3240-9. PubMed ID: 21413765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.
    Thibault B; Clement E; Zorza G; Meignan S; Delord JP; Couderc B; Bailly C; Narducci F; Vandenberghe I; Kruczynski A; Guilbaud N; Ferré P; Annereau JP
    Cancer Lett; 2016 Jan; 370(1):10-8. PubMed ID: 26404751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma.
    Tierny D; Serres F; Segaoula Z; Bemelmans I; Bouchaert E; Pétain A; Brel V; Couffin S; Marchal T; Nguyen L; Thuru X; Ferré P; Guilbaud N; Gomes B
    Clin Cancer Res; 2015 Dec; 21(23):5314-23. PubMed ID: 26169968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks.
    Bombarde O; Larminat F; Gomez D; Frit P; Racca C; Gomes B; Guilbaud N; Calsou P
    Mol Cancer Ther; 2017 Oct; 16(10):2166-2177. PubMed ID: 28611105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin siRNA inhibits gastric cancer in nude mice.
    Wenying Z; Zhaoning J; Zhimin Y; Dongyun C; Lili S
    Cell Biochem Biophys; 2012 Mar; 62(2):337-41. PubMed ID: 22052003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4'-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors.
    Zhao Y; Ge CW; Wu ZH; Wang CN; Fang JH; Zhu L
    Eur J Med Chem; 2011 Mar; 46(3):901-6. PubMed ID: 21277655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.
    Xu D; Cao J; Qian S; Li L; Hu C; Weng Q; Lou J; Zhu D; Zhu H; Hu Y; He Q; Yang B
    Invest New Drugs; 2011 Oct; 29(5):786-99. PubMed ID: 20352292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
    Sudan S; Rupasinghe HP
    Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
    Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K
    Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells.
    Cheng MH; Yang YC; Wong YH; Chen TR; Lee CY; Yang CC; Chen SH; Yang IN; Yang YS; Huang HS; Yang CY; Huang MS; Chiu HF
    Anticancer Drugs; 2012 Feb; 23(2):191-9. PubMed ID: 22008852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents.
    Kamal A; Suresh P; Ramaiah MJ; Mallareddy A; Imthiajali S; Pushpavalli SN; Lavanya A; Pal-Bhadra M
    Bioorg Med Chem; 2012 Mar; 20(6):2054-66. PubMed ID: 22364746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.